Literature DB >> 16320890

[High altitude and cardiac disease].

A Bernheim1.   

Abstract

Hypoxia at high altitude is associated with an increase in myocardial work. Cardiovascular effects of high altitude may affect patients suffering from cardiac diseases and raise questions concerning the tolerability of exposure to altitude. In general, altitudes up to 2500 to 3000 meters do not pose a hazard for a patient with stable coronary artery disease and good exercise tolerance. Likewise, a patient suffering from heart failure does not necessarily refrain from these altitude exposures unless exercise capacity and left ventricular ejection fraction are severely impaired. However, cardiac patients have to be informed that symptoms may occur already at lesser efforts at high altitude compared to low altitude. Therefore, patients should be advised to adapt physical activities, particularly during the first 3-4 days of acclimatization. In commercial airplanes pressure conditions are comparable to altitudes of 1500 to 2400 meters. Most cardiac patients tolerante the associated physical stress without difficulty. Contraindications for air travel include unstable cardiac conditions, recent cardiac interventions (2-3 weeks), an uncomplicated myocardial infarction within the last 2 weeks, or a complicated myocardial infarction within the last 6 weeks, respectively. The risk of exposure to altitudes above 3500 meters is not well known for cardiac patients because of a lack of corresponding data. Thus, patients who would like to mountaineer at very high altitudes have to be advised individually based on their physical condition and on the severity of their cardiac illness.

Entities:  

Mesh:

Year:  2005        PMID: 16320890     DOI: 10.1024/0369-8394.94.45.1760

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  2 in total

1.  Myocardial infarction in a 21-year-old healthy man on rapid ascent.

Authors:  Y C Huang; I-T Chu
Journal:  Emerg Med J       Date:  2006-11       Impact factor: 2.740

Review 2.  Navigating air travel and cardiovascular concerns: Is the sky the limit?

Authors:  Muhammad Hammadah; Bryan R Kindya; Marc P Allard-Ratick; Sammer Jazbeh; Danny Eapen; W H Wilson Tang; Laurence Sperling
Journal:  Clin Cardiol       Date:  2017-06-08       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.